Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Vomiting | 22% | x | x | |
| Nausea | 20% | x | x | |
| Diarrhoea | 19% | x | x | |
| Dyspepsia | 16% | x | x | |
| Flatulence | 8% | x | x | |
| Abdominal pain | postmarketing, 9% | x | x | |
| Constipation | postmarketing, 8% | x | x | |
| Rash | postmarketing | x | x | |
| Faecalith | postmarketing | x | ||
| Intestinal obstruction | postmarketing | x | x | |
| Intestinal perforation | postmarketing | x | x | |
| Pruritus | postmarketing | x | x | |
| Ileus | postmarketing | x | x | |
| Gastrointestinal disorder | x | |||
| Peritonitis | x | |||
| Abdominal pain upper | x | |||
| Subileus | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |